About Intron Life Sciences
Intron Life Sciences is an Agriculture company based in Hyderabad (India) founded in 2018. Manufacturer and supplier of probiotics biotech products. Intron Life Sciences has raised $12.25 million across 4 funding rounds from investors including InvAscent, Param Capital and Param Capital Research. The company has 160 employees. Intron Life Sciences was last valued at $20.01 million in December 2018. Its Indian entity Intron Life Sciences Private Limited reported revenue of ₹103 Cr. Its focus areas include Food and Agriculture and Animal Feed and Nutrition.
Company details
Intron Life Sciences was established in 2018 and is headquartered in Hyderabad, India. Operations center on the biotechnology and life sciences sector, where probiotics and related biotech products are produced and distributed. Supplies are provided to various markets, supporting applications in health and wellness. The companys activities are managed from its base in southern India, with an emphasis on quality-controlled manufacturing processes.
- Headquarters Hyderabad, India
- Employees 160
- Stage Minicorn
- SectorsAgriculture
- Email••••••••
- Phone•••• ••••
- Website intronlifesciences.com
- Legal Name Intron Life Sciences Private Limited
- Date of Incorporation 28 Sep, 2018
- Jurisdiction Gundlapalli, Andhra Pradesh, India
- Annual Revenue₹103 Cr
FY 2025 · +32% YoY
- Net Profit₹13.27 Cr
FY 2025 · 13% margin
- EBITDA₹23.75 Cr
FY 2025 · 23% margin
- Total Equity Funding$12.25M (USD)
in 4 rounds
- Latest Funding Round$1.13M (USD), Series A
Oct 2025
- InvestorsInvAscent
& 3 more
- Employee Count160
Associated legal entities of Intron Life Sciences
Intron Life Sciences operates through Intron Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Intron Life Sciences Private Limited CIN U24299AP2018PTC109365 | Active | 28 Sep 2018 | Gundlapalli, Andhra Pradesh | ₹103 Cr | 160 | 6 | View details |
Funding Insights of Intron Life Sciences
Intron Life Sciences has successfully raised a total of $12.25M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.13 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.25M
- Total Rounds 4
- Last Round Series A — $1.13M
- First Round $10M
(Dec 2018)
- Investors Count 4
All 4 funding rounds of Intron Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $1.13M | Series A | – | Param Capital Research | |
| Oct 2025 | $1.13M | Series A | – | – | – |
| Oct 2025 | Series A | – | – | ||
| Dec 2018 | $10M | Series A | $20.01M | InvAscent | – |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2018 | $20.01M | •••••••• |
Last known valuation $20.01M (Dec 2018). 4 investors in total: 3 institutional and 1 angel.
Investors in Intron Life Sciences
Intron Life Sciences has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include InvAscent, Param Capital and Param Capital Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on life sciences investments in India. | 2005 | invascent.com | ||
| unknown_64e71bfaefd9488ab | ||||
MG Manish Gupta | unknown_905c152303ae4af88 |
Investor details for Intron Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Intron Life Sciences Private Limited (Intron Life Sciences)
Intron Life Sciences Private Limited is the primary company behind Intron Life Sciences. The board of Intron Life Sciences Private Limited currently have 5 directors; the longest-serving is Sreemannarayana Murali Krishna Pasumarthi, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sreemannarayana Murali Krishna Pasumarthi DIN 03504778 | Managing Director | 28 Sep 2018 | 8 yrs 1 mo | Intron Life Sciences Private Limited |
| Pavan Kumar Velpuri DIN 07260879 | Whole-time director | 28 Sep 2018 | 8 yrs 1 mo | Intron Life Sciences Private Limited |
| Saranya Mukul Agrawal DIN 09682018 | Nominee Director | 08 Oct 2025 | 1 yr | Intron Life Sciences Private Limited |
| Vijay Ramvallabh Khetan DIN 00465161 | Nominee Director | 08 Oct 2025 | 1 yr | Intron Life Sciences Private Limited |
| Manish Gupta DIN 06805265 | Nominee Director | 08 Oct 2025 | 1 yr | Intron Life Sciences Private Limited |
People of Intron Life Sciences
8 people are tracked at Intron Life Sciences (5 in leadership, 3 in team); the tracked headcount is 160.
| Name | Role | Group |
|---|---|---|
| Chairman & Managing Director | Leadership | |
Pavan Kumar Velpur | Executive Director | Leadership |
Honey Darda | Director | Leadership |
Arnab Banerjee | Chief Marketing Officer, International Business | Leadership |
Arugunta Sreedharreddy | Director | Leadership |
Ch Hari Koteswara Rao | Senior Executive | Team |
Chandrakant Kalabhant | RSM | Team |
Sridhar Arugunta | Management | Team |
Complete people profiles for Intron Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Intron Life Sciences
Figures of Intron Life Sciences Private Limited, the primary company behind Intron Life Sciences, for FY 2025. Revenue was ₹103 Cr (+32% year on year). Net profit was ₹13.27 Cr (13% margin). EBITDA was ₹23.75 Cr (23% margin). Revenue has grown at a compounded annual rate of +26% over three years and +20% over five years.
- ₹103 CrRevenue · FY 2025 · +32% YoY
- ₹13.27 CrNet profit · 13% margin
- ₹23.75 CrEBITDA · 23% margin
- ₹20.32 CrPaid-up capital
- 160Employees (provident fund records)
- +26%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Intron Life Sciences Private Limited are on its company page.
Detailed financial statements for Intron Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Intron Life Sciences
4 dated milestones of Intron Life Sciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Intron Life Sciences is founded.
- Funding First funding round of $10.0M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $1.1M.
Top companies in Animal Feed & Nutrition
3 companies that operate in the same segment as Intron Life Sciences (Animal Feed & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Procures and distributes milk and dairy products through unions and online orders. | 1984 | Bengaluru, Karnataka, India | USD 2.58 M | |||
A brand specializing in high-quality milk and food products. | 2007 | Lucknow, Uttar Pradesh, India | USD 184.73 M | 1,016 | ||
Provides healthy snack options including potato chips, multigrain chips, and noodles for consumers. | 2016 | Kolkata, West Bengal, India | USD 51.28 M | 388 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Intron Life Sciences
Complete news archive for Intron Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intron Life Sciences
Intron Life Sciences was founded in 2018.
Intron Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Intron Life Sciences is a funded company, having raised a total of $12.25M across 4 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Dec 2018.
Intron Life Sciences has 160 employees.
The primary company behind Intron Life Sciences, Intron Life Sciences Private Limited, reported revenue of ₹103 Cr for FY 2025, up 32% year on year.
Intron Life Sciences was established in 2018 and is headquartered in Hyderabad, India. Operations center on the biotechnology and life sciences sector, where probiotics and related biotech products are produced and distributed. Supplies are provided to various markets, supporting applications in health and wellness. The companys activities are managed from its base in southern India, with an emphasis on quality-controlled manufacturing processes.
Intron Life Sciences has 4 investors. Key investors include InvAscent, Param Capital, Param Capital Research, and Manish Gupta.
The valuation of Intron Life Sciences is $20.01M as of Dec 2018.
Intron Life Sciences operates through Intron Life Sciences Private Limited.
The legal entities of Intron Life Sciences currently have 6 directors, including Saranya Mukul Agrawal, Ronak Modi, Sreemannarayana Murali Krishna Pasumarthi and others.